- Previous Close
3,580.00 - Open
3,580.00 - Bid 3,503.00 x --
- Ask 3,517.00 x --
- Day's Range
3,471.00 - 3,584.00 - 52 Week Range
2,694.00 - 4,475.00 - Volume
242,400 - Avg. Volume
243,834 - Market Cap (intraday)
236.095B - Beta (5Y Monthly) -0.24
- PE Ratio (TTM)
7.76 - EPS (TTM)
451.32 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield 124.00 (3.54%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
4,212.50
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
www.nippon-shinyaku.co.jp2,213
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: 4516.T
View MorePerformance Overview: 4516.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4516.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4516.T
View MoreValuation Measures
Market Cap
236.09B
Enterprise Value
178.47B
Trailing P/E
7.76
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.51
Price/Book (mrq)
0.95
Enterprise Value/Revenue
1.14
Enterprise Value/EBITDA
4.22
Financial Highlights
Profitability and Income Statement
Profit Margin
19.38%
Return on Assets (ttm)
7.88%
Return on Equity (ttm)
13.13%
Revenue (ttm)
156.85B
Net Income Avi to Common (ttm)
30.4B
Diluted EPS (ttm)
451.32
Balance Sheet and Cash Flow
Total Cash (mrq)
55.42B
Total Debt/Equity (mrq)
0.99%
Levered Free Cash Flow (ttm)
4.29B